Furthermore, since proteasome inhibitors can increase frataxin stability [17] and improve AAV transduction [33], it is expected to have a more positive effect on the therapy of Friedreich ataxia by GAA repeat deletion in transgenic animals. Here, FXN is linked to Friedreich ataxia.